PUBLISHER: The Business Research Company | PRODUCT CODE: 1713478
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713478
Respiratory disposables are used to connect respiratory devices, such as ventilators, nebulizers, and oxygen therapy devices, with patients. They help maintain hygiene and prevent cross-contamination during procedures that involve ventilation or oxygen delivery.
The primary categories of respiratory disposables include masks, tubes, inhalers, and other related items. Masks are typically made of cloth or similar materials and are a form of personal protective equipment with medical applications. They are utilized in the treatment of various respiratory conditions, including asthma, chronic obstructive pulmonary disorder (COPD), tuberculosis, lung cancer, and other chronic respiratory diseases. These disposables find applications across different patient groups, including adults, pediatric patients, and neonates. End-users for respiratory disposables encompass hospitals, clinics, ambulatory care centers, and other healthcare facilities.
The respiratory disposables market research report is one of a series of new reports from The Business Research Company that provides respiratory disposables market statistics, including respiratory disposables industry global market size, regional shares, competitors with a respiratory disposables market share, detailed respiratory disposables market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disposables industry. This respiratory disposable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory disposables market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.15 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to respiratory conditions prevalence, infection control, aging population, respiratory therapies.
The respiratory disposables market size is expected to see rapid growth in the next few years. It will grow to $1.89 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to minimally invasive respiratory procedures, emerging markets growth, telehealth and remote monitoring, value-based healthcare. Major trends in the forecast period include eco-friendly disposables, customized solutions, remote monitoring and data integration, advanced filter technology.
The global respiratory disposables market is experiencing significant growth due to the high prevalence of respiratory diseases worldwide. Factors such as excessive smoking, exposure to toxic substances, adverse environmental conditions, and air pollution contribute to the increasing incidence of respiratory ailments like asthma, lung cancer, Chronic Obstructive Pulmonary Disease (COPD), and obstructive sleep apnea (OSA). Notably, COPD affects around 65 million people, leading to approximately 3 million annual deaths. Additionally, asthma, often aggravated by air pollution and tobacco smoke, afflicts around 334 million individuals, increasing the demand for respiratory treatments and driving the respiratory disposables market.
The growing demand for telehealth services is anticipated to fuel the growth of the respiratory disposables market in the coming years. Telehealth involves using telecommunications technology, such as video calls, phone consultations, and secure messaging, to provide healthcare services remotely. It enables patients to have virtual consultations with healthcare professionals, especially for respiratory conditions. During these remote visits, healthcare providers can assess symptoms and recommend suitable treatments, including the use of respiratory disposables like masks, nebulizers, or inhalers. For example, there was a 7.3% national increase in telehealth use from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023, as reported by FAIR Health Inc. This surge in telehealth adoption is a key driver behind the growth of the respiratory disposables market.
Innovations in respiratory disposable manufacturing are being driven by rapid technological advancements. Key areas of development include AIR gel technology, wearable technologies, and 3D printing. These technologies are revolutionizing the production of respiratory disposables, resulting in improved productivity, reduced costs, and increased profit margins. Companies in this market are increasingly focusing on AIR gel technology, which involves incorporating gel into the mask's edges to protect the skin, create a bridge for minimal skin irritation, and ensure an effective seal. For example, Vyair Medical has developed the Veraseal 2 disposable mask for acute care, featuring AIR gel technology and available in vented and non-vented versions. Similarly, Sleepnet has introduced the Mojo ventilation masks with Airgel technology.
Major companies operating in the respiratory disposables market are introducing new products, such as small surgical N95 respirators, to enhance their profitability. Small surgical N95 respirators are designed to protect the respiratory health of medical professionals. For instance, in May 2022, Honeywell International, Inc., launched the DC365 Small Surgical N95 Respirator. This respirator is flexible, lightweight, dye-free, non-sensitizing, and conforms comfortably to the face, reducing pressure points. The materials used in the DC365 Small Surgical N95 Respirator prioritize comfort.
In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company and a division of Novartis, acquired Coalesce Product Development Limited for an undisclosed sum. Through this acquisition, Sandoz Group AG intends to strengthen its respiratory portfolio, improve patient access to complex generics, and address significant unmet medical needs in the treatment of respiratory conditions. Coalesce Product Development Limited is a UK-based company that offers end-to-end product development services, ranging from concept design to production.
Major companies operating in the respiratory disposables market include Fisher & Paykel Appliances Holdings Ltd., Becton Dickinson Company, Ambu A/S, Smiths Medical Inc., Armstrong Medical, Teleflex Incorporated, Philips Respironics, Besmed, ResMed, Dynarex Corporation, Drive Medical, Cardinal Health Inc., Drger Medical, Hamilton Medical, Mercury Medical, SunMed LLC, Ningbo Greetmed Medical Instruments Co.Ltd., Hangzhou Jinlin Medical Appliances Co. Ltd., Hangzhou Tappa Medical Technology Co. Ltd., Weihai Strong Medical Sci-Tech Co.Ltd., Vyaire MedicalInc., Viomedex Ltd., Flexicare Medical Ltd., ICU Medical Inc., GF Health Products Inc., Medline Industries Inc., Westmed Inc., Intersurgical Ltd., Salter Labs Inc., AirLife, Medtronic PLC, McKesson Corporation, Owens & Minor Inc., Henry Schein Inc., 3M Company, Johnson & Johnson, Baxter International Inc.
Asia-Pacific was the largest region in the global respiratory disposables and equipment market in 2024. Western Europe was the second-largest region in the respiratory disposables market. The regions covered in the respiratory disposables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the respiratory disposables market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The respiratory disposables market consists of sales of instruments such as disposable resuscitators, disposable masks, nasal cannulas, tracheostomy tubes, and other consumables and accessories. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Disposables Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on respiratory disposables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory disposables ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory disposables market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.